The investigational tuberculosis vaccine M72/AS01E-4 has an acceptable safety profile and robust immunogenicity among ...

Recent developments in antiretroviral therapy (ART) include longer-acting therapies that don't require a daily oral pill and ...

Lori Cannon, a renowned Chicago activist and advocate for Chicago's LGBTQ+ community and people living with HIV/AIDS, died ...

Receiving treatment within the first month of life could protect children for at least three years, a study suggests.

A single shot of gene therapy given to newborn monkeys appears to shield them from HIV, the virus that causes AIDS, for at ...

Large numbers of vulnerable HIV patients in South Africa are feared to have dropped off medication, in what campaigners warn ...

The very sayings that once shaped our conduct could be reimagined to reshape our mindsets: “Do not sweep the house at night, ...

In a small trial across ten U.S. research sites, a novel HIV vaccine candidate has shown a result that has eluded scientists ...

Led by a team of African researchers, first doses of the novel T cell-inducing GRAdHIVNE1 vaccine candidate have been given.

In Colombia, Afro-descendant women are taking the HIV response into their own hands. Faced with racism, inequality and ...

A London-wide HIV charity has said it could be forced to close if the funding crisis it is facing continues. Positively UK, ...

TWO months since pushing for the declaration of a public health emergency, the Department of Health (DOH) is bringing its ...